Adverum Biotechnologies (ADVM)
(Delayed Data from NSDQ)
$9.17 USD
-0.13 (-1.40%)
Updated May 13, 2024 04:00 PM ET
After-Market: $9.16 -0.01 (-0.11%) 7:30 PM ET
2-Buy of 5 2
D Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -1.24 |
EPS Last Quarter | -1.50 |
Last EPS Surprise | -17.19% |
ABR | 1.29 |
Earnings ESP
|
-2.83% |
---|---|
Current Year | -5.18 |
Next Year | -5.54 |
EPS (TTM) | -10.20 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.54M | 0.56M | 2.20M | 2.09M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.54M | 0.56M | 2.20M | 2.09M |
Low Estimate | 0.54M | 0.56M | 2.20M | 2.09M |
Year ago Sales | 0.00M | 0.00M | 3.60M | 2.20M |
Year over Year Growth Est. | NA | NA | -38.89% | -5.00% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.24 | -1.26 | -5.18 | -5.54 |
# of Estimates | 2 | 2 | 5 | 4 |
Most Recent Consensus | -1.27 | -1.31 | -5.17 | -5.75 |
High Estimate | -1.20 | -1.20 | -4.80 | -4.90 |
Low Estimate | -1.27 | -1.31 | -6.01 | -6.00 |
Year ago EPS | -3.10 | -3.30 | -11.60 | -5.18 |
Year over Year Growth Est. | 60.00% | 61.82% | 55.34% | -6.98% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 4 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.24 | -1.26 | -5.18 | -5.54 |
7 Days Ago | -1.24 | -1.26 | -5.18 | -5.54 |
30 Days Ago | -1.20 | -1.20 | -5.18 | -5.47 |
60 Days Ago | -1.80 | -1.80 | -7.73 | -5.50 |
90 Days Ago | -1.80 | -1.80 | -8.73 | -11.00 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.27 | -1.31 | -5.17 | -5.75 |
Zacks Consensus Estimate | -1.24 | -1.26 | -5.18 | -5.54 |
Earnings ESP | -2.83% | -4.38% | 0.12% | -3.84% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.50 | -2.30 | -3.30 | -3.10 | NA |
Estimate | -1.28 | -2.80 | -3.00 | -3.20 | NA |
Difference | -0.22 | 0.50 | -0.30 | 0.10 | 0.02 |
Surprise | -17.19% | 17.86% | -10.00% | 3.12% | -1.55% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more